RESUMEN
The Wolfram syndrome 1 gene (WFS1) is the main causative locus for Wolfram syndrome, an inherited condition characterized by childhood-onset diabetes mellitus, optic atrophy, and deafness. Global genome-wide association studies have listed at least 19 WFS1 variants that are associated with type 2 diabetes (T2D) and metabolic traits. It has been suggested that miRNA binding sites on WFS1 play a critical role in the regulation of the wolframin protein, and loss of WFS1 function may lead to the pathogenesis of diabetes. In the Hungarian population, it was observed that a 3' UTR variant from WFS1, namely rs1046322, influenced the affinity of miR-668 to WFS1 mRNA, and showed a strong association with T2D. In this study, we genotyped a large cohort of 2067 individuals of different ethnicities residing in Kuwait for the WFS1 rs1046322 polymorphism. The cohort included 362 Southeast Asians (SEA), 1045 Arabs, and 660 South Asians (SA). Upon performing genetic association tests, we observed significant associations between the rs1046322 SNP and obesity traits in the SEA population, but not in the Arab or SA populations. The associated traits in SEA cohort were body mass index, BMI (ß=1.562, P-value=0.0035, Pemp=0.0072), waist circumference, WC (ß=3.163, P-value=0.0197, Pemp=0.0388) and triglyceride, TGL (ß=0.224, P-value=0.0340). The association with BMI remained statistically significant even after multiple testing correction. Among the SEA individuals, carriers of the effect allele at the SNP had significantly higher BMI [mean of 27.63 (3.6) Kg/m2], WC [mean of 89.9 (8.1) cm], and TGL levels [mean of 1.672 (0.8) mmol/l] than non-carriers of the effect allele. Our findings suggest a role for WFS1 in obesity, which is a risk factor for diabetes. The study also emphasizes the significant role the ethnic background may play in determining the effect of genetic variants on susceptibility to metabolic diseases.
Asunto(s)
Diabetes Mellitus Tipo 2 , MicroARNs , Obesidad , Síndrome de Wolfram , Niño , Humanos , Sitios de Unión/genética , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/genética , Estudio de Asociación del Genoma Completo , MicroARNs/genética , Obesidad/epidemiología , Obesidad/genética , Pueblos del Sudeste Asiático , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genéticaRESUMEN
Wolfram syndrome 1 is a rare, autosomal recessive, neurodegenerative, progressive disorder. Insulin-dependent, non-autoimmune diabetes mellitus and bilateral progressive optic atrophy are both sensitive and specific criteria for clinical diagnosis. The leading cause of death is central respiratory failure resulting from brainstem atrophy. We describe the clinical features of fourteen patients from seven different families followed in our Diabetes Center. The mean age at Wolfram syndrome 1 diagnosis was 12.4 years. Diabetes mellitus was the first clinical manifestation, in all patients. Sensorineural hearing impairment and central diabetes insipidus were present in 85.7% of patients. Other endocrine findings included hypogonadotropic hypogonadism (7.1%), hypergonadotropic hypogonadism (7.1%), and Hashimoto's thyroiditis (21.4%). Neuropsychiatric disorders were detected in 35.7% of patients, and urogenital tract abnormalities were present in 21.4%. Finally, heart diseases were found in 14.2% of patients. Eight patients (57.1%) died at the mean age of 27.3 years. The most common cause of death was respiratory failure which occurred in six patients. The remaining two died due to end-stage renal failure and myocardial infarction. Our data are superimposable with those reported in the literature in terms of mean age of onset, the clinical course of the disease, and causes of death. The frequency of deafness and diabetes insipidus was higher in our patients. The incidence of urogenital diseases was lower although it led to the death of one patient. Long-term follow-up studies including large patient cohorts are necessary to establish potential genotype-phenotype correlation in order to personalize the most suitable clinical approach for each patient.
Asunto(s)
Diabetes Mellitus Tipo 1 , Pérdida Auditiva Sensorineural , Enfermedades Urogenitales , Síndrome de Wolfram , Adulto , Humanos , Masculino , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genéticaRESUMEN
OBJECTIVE: (1) Describe the progression of diabetes mellitus over time in an observational study of Wolfram syndrome, a rare, genetic, neurodegenerative disorder, which often includes diabetes mellitus and is typically diagnosed during childhood or adolescence. (2) Determine whether C-peptide could be used as a marker of diabetes progression in interventional trials for Wolfram syndrome. METHODS: N = 44 (25F/19M) participants with genetically confirmed Wolfram syndrome attended the Washington University Wolfram Research Clinic annually from 2010 to 2019. Medical history, physical examinations, blood sampling, and questionnaires were used to collect data about diabetes mellitus and other components of Wolfram syndrome. Beta-cell function was assessed by determination of C-peptide during a mixed meal tolerance test. Random coefficients models evaluated the rate of progression of C-peptide over time, and power analyses were used to estimate the number of subjects needed to detect a change in C-peptide decline during an intervention trial. RESULTS: 93.2% of patients had diabetes mellitus. Mean HbA1c across all study visits was 7.9%. C-peptide significantly decreased with increasing duration of diabetes mellitus (p < 0.0001); an optimal break point in C-peptide decline was identified to occur between 0.1 and 2.3 years after diabetes mellitus diagnosis. Twenty patients per group (active vs. control) were estimated to be needed to detect a 60% slowing of C-peptide decline during the first 2.3 years following diabetes diagnosis. CONCLUSION: C-peptide declines over time in Wolfram syndrome and could potentially be used as a marker of diabetes progression in interventional studies for Wolfram syndrome, especially within the first 2 years after diabetes diagnosis.
Asunto(s)
Diabetes Mellitus/etiología , Síndrome de Wolfram/complicaciones , Adolescente , Instituciones de Atención Ambulatoria/organización & administración , Instituciones de Atención Ambulatoria/estadística & datos numéricos , Distribución de Chi-Cuadrado , Niño , Diabetes Mellitus/epidemiología , Progresión de la Enfermedad , Femenino , Humanos , Estudios Longitudinales , Masculino , Washingtón/epidemiología , Síndrome de Wolfram/epidemiologíaRESUMEN
OBJECTIVE: Recessive WFS1 mutations are known to cause Wolfram syndrome, a very rare systemic disorder. However, they were also found in non-syndromic diabetes in Han Chinese misdiagnosed with type 1 diabetes (T1D), a molecular cause that appears to be considerably more common than the fully expressed syndrome. We aimed to better define the incidence and clinical features of non-syndromic diabetes due to recessive WFS1 mutation. DESIGN: We analyzed the genotype and phenotype of 320 consecutive incident Chinese pediatric diabetic patients diagnosed from 2016 to 2019 to search for non-syndromic diabetic cases due to recessive WFS1 mutation. METHODS: A cohort of 105 pancreatic autoantibody-negative patients were recruited for exome sequencing. All patients tested positive for pathogenic diallelic WFS1 mutations were examined for phenotypic features (fundoscopy, audiogram, and urine density). RESULTS: We found three cases of non-syndromic diabetes due to recessive WFS1 mutations (incidence = 0.94% (95% CI: 0.25-2.7%)). All three cases only had mild diabetes when diagnosed. All patients had well-conserved fasting C-peptide when diagnosed but one of them progressed to T1D-like insulin deficiency. In addition, we found a fourth case with previously undetected features of Wolfram syndrome. CONCLUSIONS: Non-syndromic diabetes due to WFS1 mutation may be common among Chinese pediatric patients with diabetes. It is important to differentiate it from other maturity-onset diabetes in the young subtypes with similar phenotype by molecular diagnosis because of different prognosis and, potentially, therapy.
Asunto(s)
Pueblo Asiatico/genética , Diabetes Mellitus Tipo 1/diagnóstico , Diabetes Mellitus Tipo 1/genética , Proteínas de la Membrana/genética , Mutación/genética , Fenotipo , Niño , Preescolar , Estudios de Cohortes , Diabetes Mellitus Tipo 1/epidemiología , Humanos , Masculino , Prevalencia , Secuenciación del Exoma/métodos , Síndrome de Wolfram/diagnóstico , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genéticaRESUMEN
BACKGROUND: Wolfram syndrome (WFS) is characterized by deafness, diabetes mellitus, and diabetes insipidus along with optic atrophy. WFS has an autosomal recessive mode of inheritance and is due to variants in WFS1 and CISD2. METHODS: We evaluated the underlying molecular etiology of three affected members of a consanguineous family with hearing impairment, bicuspid aortic valve, diabetes mellitus and insipidus, clinodactyly, and gastrointestinal tract abnormalities via exome sequencing approach. We correlated clinical and imaging data with the genetic findings and their associated phenotypes. RESULTS: We identified a homozygous missense variant p.(Asn1097Lys) in CDK13, a gene previously associated with autosomal dominant congenital heart defects, dysmorphic facial features, clinodactyly, gastrointestinal tract abnormalities, intellectual developmental disorder, and seizures with variable phenotypic features. CONCLUSION: We report a homozygous variant in CDK13 and suggest that this gene causes an autosomal recessive disorder with hearing impairment, bicuspid aortic valve, diabetes mellitus and insipidus, clinodactyly, and gastrointestinal tract abnormalities.
Asunto(s)
Proteína Quinasa CDC2/genética , Sordera/genética , Predisposición Genética a la Enfermedad , Atrofia Óptica/genética , Síndrome de Wolfram/genética , Adolescente , Adulto , Enfermedad de la Válvula Aórtica Bicúspide/genética , Enfermedad de la Válvula Aórtica Bicúspide/patología , Niño , Preescolar , Consanguinidad , Sordera/complicaciones , Sordera/patología , Diabetes Mellitus/genética , Femenino , Tracto Gastrointestinal/anomalías , Tracto Gastrointestinal/metabolismo , Tracto Gastrointestinal/patología , Pérdida Auditiva , Homocigoto , Humanos , Lactante , Masculino , Mutación Missense/genética , Atrofia Óptica/complicaciones , Atrofia Óptica/patología , Síndrome de Wolfram/complicaciones , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/patología , Adulto JovenRESUMEN
OBJECTIVES: We studied 45 patients with Wolfram syndrome 1 (WS1) to describe their clinical history and to search for possible genotype-phenotype correlations. METHODS: Clinical criteria contributing to WS1 diagnosis were analyzed. The patients were classified into three genotypic classes according to type of detected mutations. RESULTS: WS1 prevalence in Italy is 0.74/1,000,000. All four manifestations of DIDMOAD were found in 46.7% of patients. Differently combined WS1 clinical features were detected in 53.3% of patients. We found 35 WFS1 different mutations and a novel missense mutation, c.1523A>G. WS1 patients were homozygotes or compound heterozygotes for WFS1 mutations except for 2 heterozygote patients (4.5%). Each genotypic group exhibited a different age onset of DM, D, and DI but not of OA. Genotypic Group 2 patients manifested a lower number of clinical manifestations compared to Groups 1 and 3. Moreover, genotypic Group 1 patients tended to have a shorter survival time than the other groups. No differences were found regarding type of clinical pictures. CONCLUSIONS: Our study suggested that molecular WFS1 typing is a useful tool for early assessment of clinical history, follow-up, and prognosis of WS1.
Asunto(s)
Proteínas de la Membrana/genética , Mutación Missense , Síndrome de Wolfram/genética , Adolescente , Adulto , Niño , Progresión de la Enfermedad , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Heterocigoto , Homocigoto , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Fenotipo , Prevalencia , Pronóstico , Síndrome de Wolfram/diagnóstico , Síndrome de Wolfram/epidemiología , Adulto JovenRESUMEN
INTRODUCTION: Hereditary optic neuropathies (HON) often begin in adulthood. However, some of them can have an early onset. These may have specific clinical features and natural histories. PATIENTS AND METHODS: Retrospective study of HON patients with onset before the age of 14 years seen in a referral center. In addition to the age of onset, we evaluated the genetic etiology, visual acuity at 15 years, last best corrected visual acuity, optic disc appearance, visual field and extra-ophthalmological manifestations. RESULTS: Forty-four patients (16 women) were included; i.e. 27.8% of all patients followed for HON. The mean age of onset was 8.5±3.3 years, with an onset earlier than 3 years in 5 patients. An etiology was not found in 8 patients. Of the remaining 36 patients, 12 had Leber's hereditary optic neuropathy (LHON), 11 had dominant optic atrophy, 12 had WS/WS-like syndrome, 2 had recessive optic atrophy and 1 had spastic paraplegia type 7. For 78 eyes of 40 patients (mean age 26.9±14.5 years), the mean last visual acuity was 0.80±0.33 LogMAR, with differences according to genetic forms. Visual acuity was less than or equal to counting fingers for 7 eyes (29.1%) of 4 WS/WS-like patients and one LHON patient. CONCLUSION: Early onset NOH are not unusual. Their visual prognosis is as severe as adult onset NOH, with variations depending on the underlying genetic causes.
Asunto(s)
Enfermedades del Nervio Óptico/epidemiología , Enfermedades del Nervio Óptico/genética , Enfermedades del Nervio Óptico/fisiopatología , Enfermedades del Nervio Óptico/terapia , Agudeza Visual/fisiología , Adolescente , Adulto , Edad de Inicio , Niño , Preescolar , Femenino , Humanos , Masculino , Atrofia Óptica Hereditaria de Leber/epidemiología , Atrofia Óptica Hereditaria de Leber/genética , Atrofia Óptica Hereditaria de Leber/fisiopatología , Atrofia Óptica Hereditaria de Leber/terapia , Estudios Retrospectivos , Agudeza Visual/genética , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genética , Síndrome de Wolfram/fisiopatología , Síndrome de Wolfram/terapia , Adulto JovenRESUMEN
AIMS: Wolfram syndrome is a rare neurodegenerative disorder with an autosomal recessive pattern of inheritance characterized by various clinical manifestations. The related gene, WFS1, encodes a transmembrane glycoprotein, named wolframin. Genetic analyses demonstrated that mutations in this gene are associated with WS type 1. Our aim in this study was to sequence WFS1 coding region in Iranian Wolfram syndrome pedigrees. METHODS: Genomic DNA was extracted from peripheral blood of 12 WS patients and their healthy parents. Exons 2-8 and the exon-intron junctions of WFS1 were sequenced. DNA sequences were compared to the reference using Sequencher software. RESULTS: Molecular analysis of WFS1 revealed six different mutations. Four novel and two previously reported mutations were identified. One novel mutation, c.1379_1381del, is predicted to produce an aberrant protein. A second novel mutation, c.1384G > T, encodes a truncated protein. Novel mutation, c.1097-1107dup (11 bp), causes a frameshift which results in a premature stop codon. We screened for the novel missense mutation, c.1010C > T, in 100 control alleles. This mutation was not found in any of the healthy controls. CONCLUSION: Our study increased the spectrum of WFS1 mutations and supported the role of WFS1 in susceptibility to WS. We hope that these findings open new horizons to future molecular investigations which may help to prevent and treat this devastating disease.
Asunto(s)
Proteínas de la Membrana/genética , Síndrome de Wolfram , Adulto , Femenino , Mutación del Sistema de Lectura , Predisposición Genética a la Enfermedad , Pruebas Genéticas/métodos , Humanos , Irán/epidemiología , Masculino , Mutación Missense , Linaje , Síndrome de Wolfram/diagnóstico , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genéticaAsunto(s)
Síndrome de Wolfram/diagnóstico , Síndrome de Wolfram/genética , Envejecimiento Prematuro/genética , Análisis Mutacional de ADN , Exones , Pruebas Genéticas/métodos , Genotipo , Pérdida Auditiva Sensorineural/genética , Humanos , Proteínas de la Membrana/genética , Enfermedades Mitocondriales/genética , Mutación , Atrofia Óptica/genética , Patología Molecular , Medición de Riesgo , Sensibilidad y Especificidad , Síndrome de Wolfram/epidemiologíaRESUMEN
BACKGROUND: Wolfram syndrome (WFS) is a recessive neurologic and endocrinologic degenerative disorder, and is also known as DIDMOAD (Diabetes Insipidus, early-onset Diabetes Mellitus, progressive Optic Atrophy and Deafness) syndrome. Most affected individuals carry recessive mutations in the Wolfram syndrome 1 gene (WFS1). However, the phenotypic pleiomorphism, rarity and molecular complexity of this disease complicate our efforts to understand WFS. To address this limitation, we aimed to describe complications and to elucidate the contributions of WFS1 mutations to clinical manifestations in Japanese patients with WFS. METHODOLOGY: The minimal ascertainment criterion for diagnosing WFS was having both early onset diabetes mellitus and bilateral optic atrophy. Genetic analysis for WFS1 was performed by direct sequencing. PRINCIPAL FINDINGS: Sixty-seven patients were identified nationally for a prevalence of one per 710,000, with 33 patients (49%) having all 4 components of DIDMOAD. In 40 subjects who agreed to participate in this investigation from 30 unrelated families, the earliest manifestation was DM at a median age of 8.7 years, followed by OA at a median age of 15.8 years. However, either OA or DI was the first diagnosed feature in 6 subjects. In 10, features other than DM predated OA. Twenty-seven patients (67.5%) had a broad spectrum of recessive mutations in WFS1. Two patients had mutations in only one allele. Eleven patients (27.5%) had intact WFS1 alleles. Ages at onset of both DM and OA in patients with recessive WFS1 mutations were indistinguishable from those in patients without WFS1 mutations. In the patients with predicted complete loss-of-function mutations, ages at the onsets of both DM and OA were significantly earlier than those in patients with predicted partial-loss-of function mutations. CONCLUSION/SIGNIFICANCE: This study emphasizes the clinical and genetic heterogeneity in patients with WFS. Genotype-phenotype correlations may exist in patients with WFS1 mutations, as demonstrated by the disease onset.
Asunto(s)
Proteínas de la Membrana/genética , Neuroimagen , Síndrome de Wolfram/diagnóstico , Síndrome de Wolfram/genética , Adolescente , Adulto , Alelos , Niño , Complicaciones de la Diabetes/genética , Complicaciones de la Diabetes/patología , Femenino , Estudios de Asociación Genética , Humanos , Japón , Masculino , Mutación , Atrofia Óptica/genética , Atrofia Óptica/patología , Linaje , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/patologíaRESUMEN
INTRODUCTION: Wolfram syndrome (WFS) is the most frequent syndromic form of monogenic diabetes coexisting with optic atrophy and many other disorders. The aim of this study was to estimate the prevalence of Wolfram syndrome among children with diabetes in Poland. MATERIAL AND METHODS: These calculations were performed among Polish diabetic children, aged 0-18 years, from three administrative regions between January 2005 and December 2011. Epidemiological data was obtained by matching the results from the EURO-WABBPoland Project and the PolPeDiab Registry. RESULTS: Throughout the study period, we confirmed genetic diagnosis of Wolfram syndrome in 13 patients from Poland. Three patients originated from the studied regions with complete epidemiological data on paediatric diabetes. The total number of patients with diagnosed diabetes in the study equalled 2,568 cases. The prevalence of Wolfram syndrome among Polish children with diabetes is 0.12% (95% Confidence Interval 0.04-0.34%). CONCLUSIONS: We estimate that Wolfram syndrome is: 26 to 35 times less frequent than monogenic diabetes (MODY and neonatal diabetes) in the Polish paediatric population.
Asunto(s)
Diabetes Mellitus Tipo 1/epidemiología , Síndrome de Wolfram/epidemiología , Adolescente , Edad de Inicio , Niño , Preescolar , Comorbilidad , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Programas Nacionales de Salud , Polonia/epidemiologíaRESUMEN
BACKGROUND: Since the original description, there have been only few epidemiological studies of Wolfram syndrome (WS). AIM: Aims of the present paper are to ascertain WS prevalence and expression in a district of North-eastern Sicily, i.e. a geographic area where consanguineous unions are not very unusual. MATERIALS AND METHODS: Prevalence rates of WS in the Messina district were calculated by taking into consideration both the total population (653,737) and the populations included within the 0-30 year age range (202,681). We estimated the relative prevalence of WS among patients with youth-onset insulin-dependent diabetes mellitus (DM) who are currently aged under 30 years (256). RESULTS: Global WS prevalence in our district is 1:54,478, whereas prevalence among individuals under 30 is 1:16,890 and relative prevalence among patients with juvenile-onset insulin-dependent DM is 1:22.3. When compared with the patients with insulin-dependent DM of Messina district, WS patients did not exhibit significant differences in terms of biochemical features at DM onset, whereas age at DM diagnosis was significantly earlier in WS group. CONCLUSIONS: (a) WS prevalence is not so infrequent as generally expected; (b) in our series, DM presented before 10 years in 11/12 patients and ten cases have already developed all the four peculiar manifestations of WS by 26 years; (c) 9/12 patients exhibited a homozygous frameshift/truncation mutation (Y454_L459del_fsX454), which is the one most frequently found also in patients from other Italian regions; (d) age at DM diagnosis was significantly earlier in WS group than in the patients with insulin-dependent DM of Messina district.
Asunto(s)
Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genética , Adolescente , Adulto , Niño , Estudios de Cohortes , Consanguinidad , Diabetes Insípida/epidemiología , Diabetes Insípida/genética , Diabetes Mellitus Tipo 1/epidemiología , Diabetes Mellitus Tipo 1/genética , Femenino , Genotipo , Humanos , Masculino , Linaje , Fenotipo , Prevalencia , Sicilia/epidemiología , Síndrome de Wolfram/complicaciones , Adulto JovenRESUMEN
AIMS: Improvements in diagnostic methods and greater genetic awareness have brought remarkable progress in the recognition of monogenic forms of diabetes, including Wolfram syndrome (WFS). WFS is diagnosed based on clinical criteria of coexistence of diabetes mellitus and optic atrophy, and confirmed by molecular analysis; however, the condition is still sometimes misdiagnosed. To begin to understand the reasons for misdiagnosis, we conducted a retrospective analysis of WFS patients who were originally misdiagnosed. MATERIALS AND METHODS: The medical histories of 13 pediatric patients with clinical misdiagnosis of type 1 diabetes and early chronic complications made in the years 1995-2010 and who were subsequently correctly diagnosed with WFS based on genetic testing in 2008-2011 were analyzed. RESULTS: The average age of the patients at diabetes onset was 5 (4.4-6.3) years, and the mean HbA1c level at diagnosis was 9.1±2.3%. Initially, all of these patients were treated as having type 1 diabetes with progressive visual impairment despite good metabolic control (mean HbA1c 7.5±1.3%). Diagnosis of optic atrophy was made at an average age of 9 (5.9-11.5) years, which corresponds to 4 years after diabetes recognition (p=0.002). At the time of genetic analysis, the average age of the patients was 16 (12-18.7) years, which corresponds to 7 years after recognition of coexistence of diabetes mellitus and optic atrophy (p=0.007). CONCLUSIONS: Delays of at least 7 years occurred before recognition of WFS among a cohort of pediatric patients with diabetes. All patients with WFS were primarily misdiagnosed as having type 1 diabetes.
Asunto(s)
Diagnóstico Tardío , Complicaciones de la Diabetes/diagnóstico , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/diagnóstico , Errores Diagnósticos , Síndrome de Wolfram/diagnóstico , Adolescente , Edad de Inicio , Niño , Preescolar , Enfermedad Crónica , Estudios de Cohortes , Complicaciones de la Diabetes/epidemiología , Diabetes Mellitus Tipo 1/epidemiología , Femenino , Pruebas Genéticas , Humanos , Masculino , Atrofia Óptica/diagnóstico , Atrofia Óptica/genética , Polonia/epidemiología , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genéticaRESUMEN
AIMS: Type 1 diabetes mellitus (T1DM) is associated with various genetic and autoimmune diseases implicated in its etiopathogenesis. We hereby profile the clinical association of such diseases among patients from our center. METHODS: Consecutive patients of T1DM presenting to department of Endocrinology from May 1997 to December 2011 were retrospectively analyzed in context of associated clinical profile. RESULTS: Among 260 patients diagnosed as T1DM, 21 (8%) had hypothyroidism, 4 (1.5%) had hyperthyroidism and 2 (0.7%) had primary adrenal insufficiency. Eighteen patients (7%) had celiac disease, 9 (3.5%) had Turner's syndrome, 5 patients (1.9%) had Klinefelter's syndrome, whereas Down's syndrome and Noonan's syndrome was present in 2 and 1 patients (0.7%) respectively. One patient had Wolframs' syndrome and 1 patients had myasthenia gravis. Systemic lupus erythematosus and rheumatoid arthritis were present in 3 and 1 patients respectively. Total of 5 patients with cerebral palsy, 4 cases with deaf mutism, 4 cases with acute psychosis and 16 patients with depression were noted. Mean age of study patients was 20.8±9.8 years (range, 3-23 years). CONCLUSION: Various conditions including genetic (Down, Turner, Noonan, and Klinefelter's), autoimmune (thyroid and adrenal disorders, myasthenia gravis, SLE, rheumatoid arthritis) and central nervous system diseases were the associated diseases encountered in our patients. Routine screening is required for early diagnosis and treatment of associated co morbidities.
Asunto(s)
Autoinmunidad , Diabetes Mellitus Tipo 1/epidemiología , Diabetes Mellitus Tipo 1/etiología , Predisposición Genética a la Enfermedad , Tamizaje Masivo , Población Blanca/estadística & datos numéricos , Adolescente , Adulto , Artritis Juvenil/epidemiología , Enfermedad Celíaca/epidemiología , Parálisis Cerebral/epidemiología , Niño , Preescolar , Comorbilidad , Sordera/epidemiología , Depresión/epidemiología , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/inmunología , Síndrome de Down/epidemiología , Femenino , Humanos , India/epidemiología , Síndrome de Klinefelter/epidemiología , Lupus Eritematoso Sistémico/epidemiología , Masculino , Miastenia Gravis/epidemiología , Síndrome de Noonan/epidemiología , Estudios Retrospectivos , Enfermedades de la Tiroides/epidemiología , Síndrome de Turner/epidemiología , Síndrome de Wolfram/epidemiologíaRESUMEN
AIMS/HYPOTHESIS: The aim of this study was to study dynamic changes in the prevalence of different types of diabetes in paediatric populations in Poland, with a specific focus on monogenic diabetes (MD). METHODS: Using epidemiologic data (PolPeDiab Collaboration) and nationwide genetic test results (TEAM Programme), we compared the prevalence of type 1, type 2 and cystic fibrosis-related diabetes (CFRD) and MD. Genetically confirmed MD included MODY, neonatal diabetes and Wolfram and Alström syndromes. The study covered all children aged 0-18 years treated for diabetes between 2005 and 2011 in three regions, inhabited by 23.7% (1,989,988) of Polish children, with a low prevalence of childhood obesity (<5%). RESULTS: The prevalence of type 1 diabetes showed a continuous increase, from 96 to 138/100,000 children. The prevalence of type 2 diabetes and CFRD also increased, from 0.3 to 1.01/100,000 children and from 0.1 to 0.95/100,000 children, respectively. The prevalence of MD was stable at between 4.2 and 4.6/100,000 children, accounting for 3.1-4.2% of children with diabetes, with glucokinase (GCK)-MODY being the most frequent type, amounting to 83% of patients with MD. The percentage of positive test results decreased with the number of referrals, suggesting that children with the highest probability of MD were referred initially, followed by those with a less clear-cut phenotype. The prevalence of neonatal diabetes equalled 1 in 300,000 children. CONCLUSIONS/INTERPRETATION: The prevalence of MD in a paediatric population with a low prevalence of obesity remains stable and is nearly fivefold higher than that of type 2 diabetes and CFRD, justifying a need for increased access to genetic diagnostic procedures in diabetic children.
Asunto(s)
Diabetes Mellitus/epidemiología , Diabetes Mellitus/genética , Pruebas Genéticas , Programas Nacionales de Salud/estadística & datos numéricos , Adolescente , Síndrome de Alstrom/epidemiología , Síndrome de Alstrom/genética , Niño , Preescolar , Fibrosis Quística/complicaciones , Diabetes Mellitus/clasificación , Diabetes Mellitus Tipo 1/epidemiología , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/genética , Humanos , Lactante , Recién Nacido , Polonia/epidemiología , Prevalencia , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genéticaRESUMEN
AIMS: Wolfram syndrome, also known as DIDMOAD, is a relatively rare inherited neurodegenerative disorder, first evident in childhood as an association of juvenile-onset diabetes mellitus and optic atrophy, followed by diabetes insipidus and deafness. The aim of the study was to examine the clinical profile of patients with DIDMOAD syndrome presenting to a tertiary care hospital in north India. METHODS: Clinical presentation of juvenile-onset diabetes mellitus fulfilling the diagnosis of Wolfram syndrome was studied using a prepared standardized form. RESULTS: Subjects with juvenile-onset non-autoimmune diabetes mellitus attending the diabetic clinic at a tertiary care centre in north India were followed for 10 years and a diagnosis of fully developed Wolfram syndrome was confirmed in seven individuals. The series consisted of five male and two female patients with a mean age of 17.5 ±7.34 years. Two subjects had consanguinity and none had any other family member affected. Optic atrophy was present in all, sensorineural hearing loss in 4/7, central diabetes insipidus in 4/7 and nephrogenic diabetes insipidus in 2/7 subjects. The new associations found were: spastic myoclonus, short stature with pancreatic malabsorption, nephrogenic diabetes insipidus, cyanotic heart disease and choledocholithiasis with cholangitis. Genetic analysis revealed mutation in exon 8 of the WFS1 gene in all the cases studied. CONCLUSIONS: The present clinical series of Wolfram syndrome reveals a varied clinical presentation of the syndrome and some new associations.
Asunto(s)
Pérdida Auditiva Sensorineural/diagnóstico , Proteínas de la Membrana/genética , Mutación , Atrofia Óptica/diagnóstico , Síndrome de Wolfram/diagnóstico , Adolescente , Adulto , Secuencia de Bases , Niño , Colangitis/diagnóstico , Coledocolitiasis/diagnóstico , Consanguinidad , Análisis Mutacional de ADN , Femenino , Trastornos del Crecimiento/diagnóstico , Pérdida Auditiva Sensorineural/epidemiología , Pérdida Auditiva Sensorineural/genética , Humanos , India/epidemiología , Imagen por Resonancia Magnética , Síndromes de Malabsorción/diagnóstico , Masculino , Mioclonía/diagnóstico , Atrofia Óptica/epidemiología , Atrofia Óptica/genética , Linaje , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genética , Adulto JovenRESUMEN
Wolfram syndrome (also known as DIDMOAD = diabetes insipidus, diabetes mellitus, optic atrophy, deafness) is an autosomal recessive disorder characterized by the association of childhood non-immune insulin-dependent diabetes mellitus (DM) with progressive bilateral optic atrophy. Additional symptoms including signs of severe neurodegeneration and psychiatric illness are likely to evolve over time resulting in premature death. We report on two siblings of Turkish origin from our diabetes clinic who were diagnosed with Wolfram syndrome after 6 years and 2 years duration of DM, respectively. Subtle symptoms such as attitude changes, growing reading difficulties in the history of children or adolescents with antibody negative and ketone negative DM should alert the treating physician and lead to re-evaluation of the diagnosis, keeping in mind that not all juvenile DM is type 1 DM.
Asunto(s)
Diabetes Mellitus Tipo 1/diagnóstico , Síndrome de Wolfram/diagnóstico , Adolescente , Edad de Inicio , Niño , Trastornos de la Conducta Infantil/diagnóstico , Diagnóstico Diferencial , Femenino , Humanos , Discapacidades para el Aprendizaje/diagnóstico , Masculino , Proteínas de la Membrana/genética , Hermanos , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/fisiopatología , Síndrome de Wolfram/psicologíaRESUMEN
Objetivo: Conocer factores relevantes que inciden en la calidad de vida de los padres de personas afectadas por esta enfermedad. Diseño: Estudio analítico de casos y controles. Emplazamiento: Domicilio familiar de los afectados. Población y muestra: Familiares de aquejados por el síndrome de Wolfram en España. Se tomó contacto con pacientes diagnosticados en hospitales y sus familiares a través de esos mismos centros. Con la creación de la Asociación Española del Síndrome de Wolfram, en 1999, se conocieron nuevos pacientes y sus familias. La muestra procede de estas fuentes y está integrada por 17 familias (23 personas afectadas). Intervenciones: Se aplicó el Cuestionario de Calidad de Vida a los pacientes y sus familiares; una entrevista estructurada a los padres para conocer las reacciones manifestadas al saber que su hijo padecía una enfermedad crónica degenerativa. Se analizó el impacto económico, social y de pareja en la vida diaria; igualmente se atendieron las conductas de afrontamiento y los logros alcanzados en esta línea. Resultados: Las variables generales tomadas en conjunto no muestran diferencias significativas entre el grupo de pacientes y el de control. Tras un análisis más detallado de los ítem que componen el cuestionario CCV se desprende que las actividades sociales de los familiares se ven mermadas, los padres requieren mayor apoyo psicológico y necesitan un mínimo de dos años de adaptación a estas nuevas circunstancias. Conclusiones: La calidad de vida de los familiares cuidadores de enfermos DIDMOAD se ve afectada en algunos aspectos, se encontraron diferencias con relación al grupo control. Estas diferencias no alcanzan significación estadística pero resultan relevantes de cara a la intervención clínica con estos pacientes y sus familiares.
Asunto(s)
Calidad de Vida , España , Encuestas y Cuestionarios , Síndrome de Wolfram/diagnóstico , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/etnología , Síndrome de Wolfram/genéticaRESUMEN
Objetivo: Conocer factores relevantes que inciden en la calidad de vida de los padres de personas afectadas por esta enfermedad. Diseño: Estudio analítico de casos y controles. Emplazamiento: Domicilio familiar de los afectados. Población y muestra: Familiares de aquejados por el síndrome de Wolfram en España. Se tomó contacto con pacientes diagnosticados en hospitales y sus familiares a través de esos mismos centros. Con la creación de la Asociación Española del Síndrome de Wolfram, en 1999, se conocieron nuevos pacientes y sus familias. La muestra procede de estas fuentes y está integrada por 17 familias (23 personas afectadas). Intervenciones: Se aplicó el Cuestionario de Calidad de Vida a los pacientes y sus familiares; una entrevista estructurada a los padres para conocer las reacciones manifestadas al saber que su hijo padecía una enfermedad crónica degenerativa. Se analizó el impacto económico, social y de pareja en la vida diaria; igualmente se atendieron las conductas de afrontamiento y los logros alcanzados en esta línea. Resultados: Las variables generales tomadas en conjunto no muestran diferencias significativas entre el grupo de pacientes y el de control. Tras un análisis más detallado de los ítem que componen el cuestionario CCV se desprende que las actividades sociales de los familiares se ven mermadas, los padres requieren mayor apoyo psicológico y necesitan un mínimo de dos años de adaptación a estas nuevas circunstancias. Conclusiones: La calidad de vida de los familiares cuidadores de enfermos DIDMOAD se ve afectada en algunos aspectos, se encontraron diferencias con relación al grupo control. Estas diferencias no alcanzan significación estadística pero resultan relevantes de cara a la intervención clínica con estos pacientes y sus familiares.(AU)
Asunto(s)
Síndrome de Wolfram/diagnóstico , Síndrome de Wolfram/etnología , Síndrome de Wolfram/epidemiología , Síndrome de Wolfram/genética , Calidad de Vida , Encuestas y Cuestionarios , EspañaRESUMEN
Wolfram syndrome (WS), an infrequent cause of diabetes mellitus, derives its name from the physician who first reported the combination of juvenile-onset diabetes mellitus and optic atrophy. Also referred to as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy and deafness), it is an autosomal recessive neurodegenerative disease characterized by various clinical manifestations, such as diabetes mellitus, optic atrophy, diabetes insipidus, deafness, neurological symptoms, renal tract abnormalities, psychiatric manifestations and gonadal disorders. The condition is very rare with an estimated prevalence of one in 770,000 of the normal population, one out of 150 cases of juvenile-onset insulin-dependent diabetes mellitus, and with a carrier frequency of one in 354. This progressive neurodegenerative disease usually results in death before the age of 50 years and many patients lead a morbid life. The pathogenesis of the disorder although unknown is ascribed to mutation of a gene on chromosome 4p encoding a transmembrane protein of undetermined function called wolframin. This review summarizes the variable presentation of the disorder, its widespread complications, poor quality of life in affected individuals, and the problems in diagnosis and treatment of the syndrome.